IDIS Tips and News


FDA Advisory Committee Meetings

PDF of this tip

FDA Advisory Committee meeting documents may be found by searching Descriptor: FDA ADVISORY COMMITTEE 164.

Advisory committees often review and discuss the pivotal drug trial(s) of investigational new drugs and submit their opinion of the safety and efficacy of the drug to the FDA. Meetings discussing post-marketing safety and efficacy of FDA Approved drugs are also common.

Briefing Information from Drug Sponsor, Briefing Information from FDA, Transcript and Slides, Summary Minutes, and Notice of Meeting are the most common documents made available from an FDA Advisory Committee meeting.
    
More Tips

Login to IDIS


NOTICE:
IDIS database discontinuation December 31, 2014.
Read more.

Your institution might be using IP authentication. If you do not know your Username and Password, try clicking the "Login by IP" button.


   
*Leave Username and Password blank.


 Username:  
 Password:  

       

 


IDIS Logo

  IDIS Drug Database 1966 - December 2014

Full-text articles/reports from 1988 through the current month are available in IDIS Drug Database.

IDIS is a database of index records to articles about drugs and drug therapy in humans taken from over 200 leading medical and pharmaceutical journals, FDA approval packages, FDA Advisory Committee briefing documents, FDA boxed warnings, AHRQ publications, National Institute for Health and Clinical Excellence (NICE) guidelines and appraisals, clinical practice guidelines and more. The complete article/report is also available online (1988 through the current month). The system is designed to retrieve specific information concerning a drug and/or drug treatment of a disease state. Authoritative publications have been selected to provide broad coverage of both general and specialty areas of pharmacy and medicine.

System Usage: Data retrieved from the database is intended for distribution solely within the subscriber's organization and may not be accessed from more than one computer concurrently without prior written permission from DDIS. The data is not to be transferred, retransmitted or used with other information for the creation of a combined or consolidated database. Under no circumstances may copies of the data be offered for sale or resale.

Division of Drug Information Service
University of Iowa Research Park
2500 Crosspark Road, Room W145
Coralville, IA 52241-4710 USA

Telephone: 319-335-4800
U.S. Toll-free: 800-525-4347
Fax: 319-335-4440
E-mail: idis@uiowa.edu